131 related articles for article (PubMed ID: 12610740)
1. Effect of ciprofloxacin on the pharmacokinetics of ropivacaine.
Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ
Eur J Clin Pharmacol; 2003 Feb; 58(10):653-7. PubMed ID: 12610740
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.
Arlander E; Ekström G; Alm C; Carrillo JA; Bielenstein M; Böttiger Y; Bertilsson L; Gustafsson LL
Clin Pharmacol Ther; 1998 Nov; 64(5):484-91. PubMed ID: 9834040
[TBL] [Abstract][Full Text] [Related]
3. Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine.
Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ
Clin Pharmacol Ther; 2001 Oct; 70(4):344-50. PubMed ID: 11673750
[TBL] [Abstract][Full Text] [Related]
4. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine.
Jokinen MJ; Ahonen J; Neuvonen PJ; Olkkola KT
Anesth Analg; 2000 Nov; 91(5):1207-12. PubMed ID: 11049910
[TBL] [Abstract][Full Text] [Related]
5. Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine.
Jokinen MJ; Ahonen J; Neuvonen PJ; Olkkola KT
Pharmacol Toxicol; 2001 Apr; 88(4):187-91. PubMed ID: 11322176
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block.
Pere P; Salonen M; Jokinen M; Rosenberg PH; Neuvonen PJ; Haasio J
Anesth Analg; 2003 Feb; 96(2):563-9, table of contents. PubMed ID: 12538213
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450.
Oda Y; Furuichi K; Tanaka K; Hiroi T; Imaoka S; Asada A; Fujimori M; Funae Y
Anesthesiology; 1995 Jan; 82(1):214-20. PubMed ID: 7832304
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of ropivacaine in humans.
Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
[TBL] [Abstract][Full Text] [Related]
9. Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine.
Berggren S; Lennernäs P; Ekelund M; Weström B; Hoogstraate J; Lennernäs H
J Pharm Pharmacol; 2003 Jul; 55(7):963-72. PubMed ID: 12906753
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ropivacaine in patients with chronic renal failure.
Pere PJ; Ekstrand A; Salonen M; Honkanen E; Sjövall J; Henriksson J; Rosenberg PH
Br J Anaesth; 2011 Apr; 106(4):512-21. PubMed ID: 21307007
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Differences Between the Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion: A Prospective, Randomized, Multicenter, Double-Blind Controlled Trial.
Perotti L; Cusato M; Ingelmo P; Niebel TL; Somaini M; Riva F; Tinelli C; De Andrés J; Fanelli G; Braschi A; Regazzi M; Allegri M
Anesth Analg; 2015 Aug; 121(2):348-56. PubMed ID: 25977992
[TBL] [Abstract][Full Text] [Related]
12. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
Ekström G; Gunnarsson UB
Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
[TBL] [Abstract][Full Text] [Related]
13. Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, 2', 6'-Pipecoloxylidide, on human liver microsomes in vitro.
Tanaka E; Nakamura T; Inomata S; Honda K
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):181-3. PubMed ID: 16445592
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine.
Sandler AN; Arlander E; Finucane BT; Taddio A; Chan V; Milner A; Callahan-Enright SO; Friedlander M; Muzyka D
Can J Anaesth; 1998 Sep; 45(9):843-9. PubMed ID: 9818106
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children.
Aarons L; Sadler B; Pitsiu M; Sjövall J; Henriksson J; Molnár V
Br J Anaesth; 2011 Sep; 107(3):409-24. PubMed ID: 21693469
[TBL] [Abstract][Full Text] [Related]
16. Effect of ciprofloxin on the pharmacokinetics of intravenous lidocaine.
Isohanni MH; Ahonen J; Neuvonen PJ; Olkkola KT
Eur J Anaesthesiol; 2005 Oct; 22(10):795-9. PubMed ID: 16211753
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.
Jokinen MJ; Neuvonen PJ; Lindgren L; Höckerstedt K; Sjövall J; Breuer O; Askemark Y; Ahonen J; Olkkola KT
Anesthesiology; 2007 Jan; 106(1):43-55. PubMed ID: 17197844
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic determination of ropivacaine, 3-hydroxy-ropivacaine, 4-hydroxy-ropivacaine and 2',6'-pipecoloxylidide in plasma.
Reif S; Le Corre P; Dollo G; Chevanne F; Le Verge R
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):239-44. PubMed ID: 9869387
[TBL] [Abstract][Full Text] [Related]
19. Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers.
Ginosar Y; Haroutounian S; Kagan L; Naveh M; Aharon A; Davidson EM
Anesth Analg; 2016 May; 122(5):1673-80. PubMed ID: 27057798
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.
Granfors MT; Backman JT; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2004 Dec; 76(6):598-606. PubMed ID: 15592331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
